What Does Microba Life Sciences Do?

Total employees99
HeadquartersWoolloongabba
Founded2018

Microba Life Sciences (ASX: MAP) is a precision microbiome science company dedicated to advancing human health through groundbreaking analysis of the gut microbiome. Leveraging world-leading technology, Microba offers comprehensive gut microbiome testing services for consumers, clinicians, and researchers. The company also engages in the discovery and development of novel therapeutics derived from the human gut microbiome, targeting chronic diseases. Microba's data-driven approach aims to unlock the complex connections between the microbiome and health, paving the way for personalized medicine and innovative treatments.

Where Is Microba Life Sciences's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, laboratory operations, bioinformatics, product development, commercial activities, and corporate administration.

Notable Features:

Co-located within the Translational Research Institute (TRI), a world-class biomedical research facility. This provides access to state-of-the-art laboratories, cutting-edge equipment, and a collaborative environment with leading researchers and clinicians.

Work Culture:

Microba fosters an innovative, collaborative, and scientifically rigorous work culture. Employees are driven by a shared mission to improve human health through microbiome science, emphasizing teamwork, continuous learning, and a commitment to excellence.

HQ Significance:

The location within TRI is highly significant, facilitating direct collaboration with academic and clinical partners, accelerating research translation, and positioning Microba at the forefront of microbiome innovation.

Values Reflected in HQ: The headquarters' setting and operations reflect Microba's core values of scientific excellence, innovation, collaboration, and a commitment to translating research into tangible health outcomes.

Location:

Microba supports global pharmaceutical companies in drug discovery and development programs through its advanced microbiome analysis and data insights. Its testing services are available to consumers and clinicians in Australia, New Zealand, the United Kingdom, and selected other European countries. In the United States, testing and research services are facilitated through its subsidiary Microba Inc. and strategic partnerships with major diagnostic providers like Quest Diagnostics and Genova Diagnostics.

Street Address:

Translational Research Institute (TRI), 37 Kent Street

City:

Woolloongabba

State/Province:

QLD

Country:

Australia

Where Else Does Microba Life Sciences Operate Around the World?

USA

Address: Not publicly specified (US-based subsidiary operations)

To facilitate and expand Microba's research services, clinical trial support, and commercial partnerships within the United States, a key market for microbiome research and therapeutic development.

Buying Intent Signals for Microba Life Sciences

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Microba Life Sciences? Meet the Executive Team

As of April 2025, Microba Life Sciences' leadership includes:

Dr Luke Reid - Chief Executive Officer
Ian Smith - Chief Financial Officer
Dr Alena Pribyl - Chief Scientific Officer
Dr Páraic Ó Cuív - Co-founder & Chief Technology Officer
Kylie Ellis - Head of Operations
Rebecca Knights - Head of Product
Dr Trent Munro - Head of Discovery & Translational Science

Who's Investing in Microba Life Sciences?

Microba Life Sciences has been backed by several prominent investors over the years, including:

Sonic Healthcare (Strategic Investor & Partner)
Alium Capital Management (Pre-IPO)
Perennial Value Management (Pre-IPO)
JBell (Pre-IPO)
Publicly traded on the Australian Securities Exchange (ASX: MAP)

What Leadership Changes Has Microba Life Sciences Seen Recently?

Hire1
Exits0

In the past 12-15 months, Microba has strengthened its scientific leadership with a key appointment. The executive team has otherwise demonstrated stability with no major departures reported.

New Appointments:

Dr Trent Munro, Dr Trent Munro appointed as Head of Discovery & Translational Science, bringing extensive experience in biopharmaceutical development and translational science to accelerate Microba's therapeutic pipeline.

What Technology (Tech Stack) Is Used byMicroba Life Sciences?

Discover the tools Microba Life Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Microba Life Sciences Email Formats and Examples

Microba commonly uses the [firstname].[lastname]@microba.com email format for its employees. Other general contact emails include info@microba.com for general inquiries, media@microba.com for media relations, and investors@microba.com for investor relations.

[firstname].[lastname]@microba.com

Format

jane.doe@microba.com

Example

95%

Success rate

What's the Latest News About Microba Life Sciences?

Business WireMay 1, 2024

Microba and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics for Autoimmune Diseases

Microba Life Sciences and Ginkgo Bioworks have partnered to identify novelষেLive Bacterial Therapeutics (LBTs) for autoimmune diseases by leveraging Microba's human-first, data-driven therapeutic discovery platform and Ginkgo's horizontal cell programming platform....more

Microba News / ASXApril 29, 2024

Microba's Novel IBD Therapy Program Delivers Positive Results Demonstrating Disease Modifying Activity in Preclinical Models

Microba announced positive preclinical results for its MAP317 Inflammatory Bowel Disease (IBD) therapeutic program, showing significant disease-modifying effects and potential for a first-in-class treatment....more

Microba News / ASXFebruary 27, 2024

Microba Delivers Strong H1 FY24 Results Driven by Growth in Services and Therapeutic Development

Microba reported strong financial results for the first half of FY24, with significant revenue growth from its microbiome testing services and advancements in its therapeutic development programs, including a partnership with Pfizer....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Microba Life Sciences, are just a search away.